1,898
Views
21
CrossRef citations to date
0
Altmetric
Research Article

2-Hydroxyoleic acid-inserted liposomes as a multifunctional carrier of anticancer drugs

, , , , , , , & show all
Pages 1587-1597 | Received 22 Aug 2017, Accepted 02 Oct 2017, Published online: 13 Oct 2017

References

  • Barcelo-Coblijn G, Martin ML, De Almeida RF, et al. (2011). Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad Sci USA 108:19569–74.
  • Barry J, Fritz M, Brender JR, et al. (2009). Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin. J Am Chem Soc 131:4490–8.
  • Cerezo J, Zuniga J, Bastida A, et al. (2011). Atomistic molecular dynamics simulations of the interactions of oleic and 2-hydroxyoleic acids with phosphatidylcholine bilayers. J Phys Chem B 115:11727–38.
  • Choi JH, Lee YJ, Kim D. (2017). Image-guided nanomedicine for cancer. J Pharm Investig 47:51–64.
  • Cordeiro Pedrosa LR, Van Tellingen O, Soullie T, et al. (2015). Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model. Eur J Pharm Biopharm 94:207–19.
  • Deniz A, Sade A, Severcan F, et al. (2010). Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics. Biosci Rep 30:365–73.
  • Escriba PV, Busquets X, Inokuchi J, et al. (2015). Membrane lipid therapy: modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Prog Lipid Res 59:38–53.
  • Hong SS, Choi JY, Kim JO, et al. (2016). Development of paclitaxel-incorporated liposomal nanocarrier stabilized by triglyceride incorporation. Int J Nanomedicine 11:4465–77.
  • Hong SS, Kim SH, Lim SJ. (2015). Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes. Int J Pharm 483:142–50.
  • Hu T, Cao H, Yang C, et al. (2016). LHD-modified mechanism-based liposome coencapsulation of mitoxantrone and prednisolone using novel lipid bilayer fusion for tissue-specific colocalization and synergistic antitumor effects . ACS Appl Mater Interfaces 8:6586–601.
  • Huang CM, Chen CH, Pornpattananangkul D, et al. (2011). Eradication of drug resistant staphylococcus aureus by liposomal oleic acids. Biomaterials 32:214–21.
  • Ibarguren M, Lopez DJ, Escriba PV. (2014). The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim Biophys Acta 1838:1518–28.
  • Kim CH, Lee SG, Kang MJ, et al. (2017). Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting. J Pharm Investig 47:203–27.
  • Lee EH, Hong SS, Kim SH, et al. (2014). Computed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxel. Pharm Res 31:2022–34.
  • Li C, Cui J, Wang C, et al. (2008). Encapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacy. Eur J Pharm Biopharm 70:657–65.
  • Llado V, Gutierrez A, Martinez J, et al. (2010). Minerval induces apoptosis in Jurkat and other cancer cells. J Cell Mol Med 14:659–70.
  • Maeda H, Wu J, Sawa T, et al. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–84.
  • Martin ML, Barcelo-Coblijn G, De Almeida RF, et al. (2013). The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid. Biochim Biophys Acta 1828:1405–13.
  • Megha, London E. (2004). Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem 279:9997–10004.
  • Needham D, Mcintosh TJ, Evans E. (1988). Thermomechanical and transition properties of dimyristoylphosphatidylcholine/cholesterol bilayers. Biochemistry 27:4668–73.
  • Niles RM. (2003). Vitamin A (retinoids) regulation of mouse melanoma growth and differentiation. J Nutr 133:282S–6S.
  • Niu M, Tan Y, Guan P, et al. (2014). Enhanced oral absorption of insulin-incorporated liposomes containing bile salts: a mechanistic study. Int J Pharm 460:119–30.
  • Notman R, Noro MG, Anwar J. (2007). Interaction of oleic acid with dipalmitoylphosphatidylcholine (DPPC) bilayers simulated by molecular dynamics. J Phys Chem B 111:12748–55.
  • Noy N. (2010). Between death and survival: retinoic acid in regulation of apoptosis. Annu Rev Nutr 30:201–17.
  • Park JY, Kim M-G, Shim G, et al. (2016). Lipid-based antigen delivery systems. J Pharm Investig 46:295–304.
  • Piotto S, Concilio S, Bianchino E, et al. (2014). Differential effect of 2-hydroxyoleic acid enantiomers on protein (sphingomyelin synthase) and lipid (membrane) targets. Biochim Biophys Acta 1838:1628–37.
  • Prades J, Funari SS, Gomez-Florit M, et al. (2012). Effect of a 2-hydroxylated fatty acid on cholesterol-rich membrane domains. Mol Membr Biol 29:333–43.
  • Senior J, Gregoriadis G. (1982). Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci 30:2123–36.
  • Shapira A, Markman G, Assaraf YG, et al. (2010). Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity. Nanomedicine 6:547–55.
  • Siddikuzzaman, Grace VM. (2012). Inhibition of metastatic lung cancer in C57BL/6 mice by liposome incorporated all trans retinoic acid (ATRA). Int Immunopharmacol 14:570–9.
  • Silva EL, Lima FA, Carneiro G, et al. (2016). Improved in vitro antileukemic activity of all-trans retinoic acid incorporated in cholesteryl butyrate solid lipid nanoparticles. J Nanosci Nanotechnol 16:1291–300.
  • Srisuk P, Thongnopnua P, Raktanonchai U, et al. (2012). Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int J Pharm 427:426–34.
  • Teres S, Llado V, Higuera M, et al. (2012). 2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy. Proc Natl Acad Sci USA 109:8489–94.
  • Ugurel S, Röhmel J, Ascierto PA, et al. (2016). Survival of patients with advanced metastatic melanoma: the impact of novel therapies. Eur J Cancer 53:125–34.
  • Wrobel D, Ionov M, Gardikis K, et al. (2011). Interactions of phosphorus-containing dendrimers with liposomes. Biochim Biophys Acta 1811:221–6.
  • Zhao M, Sano D, Pickering CR, et al. (2011). Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res 17:7248–64.